ADx Neurosciences, based in Ghent, Belgium, specializes in developing biomarker assays for neurodegenerative diseases. Collaborating with academic institutions, pharmaceutical companies, and IVD partners, ADx aims to enhance diagnostics and drug development. The company’s Certified Biobank ensures ethical handling of patient samples, and their assays meet stringent industry standards for reliability. As part of a key life sciences hub, ADx has access to top-tier research talent and actively participates in regulatory standardization within the field. Their milestone-based project management ensures timely delivery, and they are pursuing ISO certification for antibody production to further guarantee quality.